People: St. Jude Medical Inc (STJ)

STJ on New York Consolidated

74.74USD
21 May 2015
Change (% chg)

-- (--)
Prev Close
$74.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,790,628
52-wk High
$75.73
52-wk Low
$54.80

Search Stocks

Summary

Name Age Since Current Position

Daniel Starks

60 2004 Chairman of the Board, President, Chief Executive Officer

Donald Zurbay

47 2012 Chief Financial Officer, Vice President - Finance

Joel Becker

47 2014 President - Americas Division

Eric Fain

54 2014 Group President - St. Jude Medical

Denis Gestin

51 2008 President - International

Michael Rousseau

59 2014 Chief Operating Officer

John Heinmiller

60 2012 Executive Vice President

Mark Murphy

46 2013 Vice President - Information Technology, Chief Information Officer

Lisa Andrade

43 2014 Chief Marketing Officer, Vice President

I. Paul Bae

50 2015 Chief Marketing Officer, Vice President - Global Human Resources

Scott Thome

52 2014 Vice President - Global Operations and Supply Chain

Jason Zellers

49 2011 Vice President, General Counsel, Corporate Secretary

Jeffrey Dallager

40 2014 Vice President, Corporate Controller

Mark Carlson

59 2013 Vice President - Global Clinical Affairs, Chief Medical Officer

Rachel Ellingson

45 2012 Vice President - Corporate Relations

Jeff Fecho

54 2012 Vice President - Global Quality

John Brown

80 2006 Independent Presiding Director

Richard Devenuti

57 2001 Independent Director

Stuart Essig

53 1999 Independent Director

Barbara Hill

62 2007 Independent Director

Michael Rocca

70 2004 Independent Director

Stefan Widensohler

54 2013 Independent Director

Wendy Yarno

60 2002 Independent Director

J. Weigelt

Director - Investor Relations

Biographies

Name Description

Daniel Starks

Mr. Daniel J. Starks is Chairman of the Board, President, Chief Executive Officer of St. Jude Medical Inc. President and Chief Operating Officer of St. Jude Medical from January 2001 to May 2004. From April 1998 to February 2001, President and Chief Executive Officer of the Cardiac Rhythm Management Division of St. Jude Medical. Previously, Chief Executive Officer and President, Daig Corporation

Donald Zurbay

Mr. Donald J. Zurbay is Chief Financial Officer, Vice President - Finance of St. Jude Medical Inc. Mr. Zurbay joined St. Jude Medical in 2003 as Director of Corporate Finance. In 2004, Mr. Zurbay was named Corporate Controller, and in January 2006 he was named Vice President, Finance and Corporate Controller. In August 2012, Mr. Zurbay was promoted to Chief Financial Officer.

Joel Becker

Mr. Joel D. Becker is President - Americas Division of company. Mr. Becker joined St. Jude Medical in 1993 as Senior Associate in Corporate Development. In 1999, he left the Company to join Myocor, Inc., a venture-backed heart failure company, as Senior Vice President. Mr. Becker returned to St. Jude Medical in 2002 where he held numerous leadership positions in both the Cardiovascular and Atrial Fibrillation divisions. He began serving as Vice President Program Management & Business Development for the Atrial Fibrillation Division from 2004 to February 2011. He then served as Senior Vice President, Marketing for the U.S. Division from February 2011 to October 2011. Mr. Becker was promoted in October 2011 to President, U.S. Division, which was expanded in January 2014 to become the Americas Division.

Eric Fain

Dr. Eric S. Fain, M.D., is Group President - St. Jude Medical of Company. Dr. Fain joined St. Jude Medical in 1997 as a part of our acquisition of Ventritex, Inc., where he had served since 1987. In 1998, he was named Senior Vice President, Clinical Engineering and Regulatory Affairs, Cardiac Rhythm Management. In 2002, he was appointed Senior Vice President for Development and Clinical/Regulatory Affairs for Cardiac Rhythm Management and was promoted to Executive Vice President over those functions in 2005. In July 2007, Dr. Fain became President, Cardiac Rhythm Management Division and in August 2012, he became President, Implantable Electronic Systems Division (the former Cardiac Rhythm Management and Neuromodulation divisions). Dr. Fain's responsibilities expanded in January 2014 after being promoted to Group President of St. Jude Medical where he oversees all global research and development activities, including clinical and regulatory affairs.

Denis Gestin

Mr. Denis M. Gestin is President - International of St. Jude Medical Inc. Mr. Gestin joined St. Jude Medical in 1997 as the manager of cardiac rhythm management and catheter product sales in France. He was named Managing Director of St. Jude Medical France in 1999 and was promoted to Vice President, Northern Europe & Africa in 2002. He was named President of SJM Europe, Middle East, Africa and Canada in August 2004, and in January 2008, Mr. Gestin was promoted to President, International Division.

Michael Rousseau

Mr. Michael T. Rousseau is Chief Operating Officer of St. Jude Medical Inc. Mr. Rousseau joined St. Jude Medical in 1999 as Senior Vice President, Cardiac Rhythm Management Global Marketing. In August 1999, Cardiac Rhythm Management Marketing and Sales were combined under his leadership. In January 2001, he was named President, U.S. Cardiac Rhythm Management Sales, and in July 2001, he was named President, U.S. Division, a position Mr. Rousseau held until January 2008, when he was promoted to Group President, initially responsible for the Company’s four product divisions. In November 2009, Mr. Rousseau’s Group President responsibilities were realigned, with the Company’s Cardiac Rhythm Management Division and U.S. Division reporting directly to him. Mr. Rousseau served as President, U.S. Division from November 2009 to October 2011. Mr. Rousseau continued to serve as Group President over the Cardiac Rhythm Management and Neuromodulation product divisions as well as the U.S. Division until August 2012 when his Group President responsibilities were expanded and broadened to include the Cardiovascular and Ablation Technologies Division (the former Cardiovascular and Atrial Fibrillation divisions), the Implantable Electronic Systems Division (the former Cardiac Rhythm Management and Neuromodulation divisions) and the U.S. Division. Mr. Rousseau also oversaw Global Regulatory and the Center for Innovation and Strategic Collaboration and served as the (Acting) Chief Marketing Officer. In January 2014, Mr. Rousseau was promoted to Chief Operating Officer of St. Jude Medical, expanding his responsibilities to include global sales, global marketing, technology development, operations and supply chain and quality.

John Heinmiller

Mr. John C. Heinmiller is Executive Vice President of St. Jude Medical Inc. Mr. Heinmiller joined St. Jude Medical in May 1996 as a part of our acquisition of Daig Corporation, where Mr. Heinmiller had served as Vice President of Finance and Administration since 1995. In May 1998, he was named Vice President of Corporate Business Development. In September 1998, he was appointed Vice President, Finance and Chief Financial Officer and in May 2004 was promoted to Executive Vice President. Mr. Heinmiller served as St. Jude Medical’s Chief Financial Officer from September 1998 through August 2012 and continues to serve as Executive Vice President, responsible for the global support and service functions including finance, human resources, information technology, corporate relations, legal, security and business development.

Mark Murphy

Mr. Mark W. Murphy is Vice President - Information Technology, Chief Information Officer of St. Jude Medical Inc. Mr. Murphy joined St. Jude Medical in January 2003 as Director, Corporate Information Technology. In September 2009, Mr. Murphy was named Senior Director of Enterprise Applications where he was responsible for business applications, including the global SAP program. In April 2013, Mr. Murphy was promoted to Vice President, Information Technology and Chief Information Officer.

Lisa Andrade

Ms. Lisa M. Andrade is Chief Marketing Officer, Vice President of the company. Ms. Andrade joined St. Jude Medical in 1997 as a part of our acquisition of Ventritex, Inc. She held multiple leadership positions in engineering for the Company's cardiac rhythm management business. She left the Company in 1999 to pursue other interests and rejoined us in 2006. In March 2006, Ms. Andrade was named Senior Director, Systems Engineering, Cardiac Rhythm Management and in March 2009, she became the Divisional Director, Clinical and Systems Engineering. In March 2010, Ms. Andrade was promoted to Vice President, Connectivity for the U.S. Division and in February 2011 she was named Vice President, Education and Market Development, U.S. Division. Later, in October 2011, she was named the Senior Vice President, Marketing, U.S. Division. In July 2013, Ms. Andrade was promoted to Senior Vice President, Global Strategy and Market Development, and in January 2014, she was named the Chief Marketing Officer for St. Jude Medical.

I. Paul Bae

Mr. I. Paul Bae is Chief Marketing Officer, Vice President - Global Human Resources of the company. Mr. Bae joined St. Jude Medical in January 2003 as Associate General Counsel for the United States Division and served in the legal and human resources capacity for that division until being named Vice President, Corporate Human Resources in September 2006. Mr. Bae was named Senior Vice President, Administration and General Counsel, Americas Division in December 2009. In August 2012, Mr. Bae was promoted to Deputy General Counsel, Labor and Employment and Chief Compliance Officer for St. Jude Medical, and in February 2015, Mr. Bae was named Vice President, Global Human Resources and Chief Compliance Officer for St. Jude Medical.

Scott Thome

Mr. Scott P. Thome is Vice President - Global Operations and Supply Chain of the company. Mr. Thome joined St. Jude Medical in 2000 as part of our acquisition of Vascular Science, Inc. Beginning in October 2000, Mr. Thome served as Director of Program Management and Process Development, Cardiac Surgery until October 2004 when he was promoted to Senior Director Program Management, Cardiology. In June 2005, Mr. Thome was named Vice President Operations, Cardiovascular and was subsequently promoted to Senior Vice President Operations, Cardiovascular in February 2010. In August 2012, his scope expanded to the Cardiovascular and Ablation Technologies Division (combining our legacy Cardiovascular and Atrial Fibrillation divisions). In January 2014, Mr. Thome was promoted to Vice President Global Operations and Supply Chain.

Jason Zellers

Mr. Jason A. Zellers is Vice President, General Counsel and Corporate Secretary of St. Jude Medical Inc. Mr. Zellers joined St. Jude Medical in 2006 as Vice President and General Counsel for the International Division. In October 2011, he was appointed St. Jude Medical’s Vice President, General Counsel and Corporate Secretary. Before joining St. Jude Medical, he was a partner at Armstrong Teasdale LLP and Schiff Hardin LLP and served as Senior Counsel at GE Healthcare. .

Jeffrey Dallager

Mr. Jeffrey A. Dallager is Vice President and Corporate Controller of the company. Mr. Dallager joined St. Jude Medical in October 2004 as Manager, Financial Reporting and was named Director, Financial Reporting in August 2005. In December 2006, Mr. Dallager was appointed to Vice President, Finance, Information Technology and Supply Chain for our Cardiovascular Division. In September 2009, Mr. Dallager was appointed to Senior Vice President, Finance for our U.S. Division and in January 2012, Mr. Dallager was named Senior Vice President, Finance and Supply Chain for our International Division. In January 2014, Mr. Dallager was promoted to Vice President and Corporate Controller. .

Mark Carlson

Dr. Mark D. Carlson, M.D., is Vice President - Global Clinical Affairs, Chief Medical Officer of St. Jude Medical Inc. Dr. Carlson joined St. Jude Medical in November 2006 as Chief Medical Officer and Sr. Vice President, Clinical Affairs, Cardiac Rhythm Management. In June 2007, he was promoted to Chief Medical Officer and Senior Vice President Research and Clinical affairs, Cardiac Rhythm Management and the later expanded Implantable Electronics Systems Division (the former Cardiac Rhythm Management and Neuromodulation divisions). In September 2013, Dr. Carlson was named Vice President Global Clinical Affairs and Chief Medical Officer for St. Jude Medical.

Rachel Ellingson

Ms. Rachel H. Ellingson is Vice President - Corporate Relations of St. Jude Medical Inc. Ms. Ellingson joined St. Jude Medical in November 2010 through the acquisition of AGA Medical where she served as Vice President, Business Development and Investor Relations. Prior to joining St. Jude Medical, she spent 15 years in investment banking, most recently as a Managing Director with the medical device team at Banc of America Securities (now Bank of America Merrill Lynch). In February 2011, Ms. Ellingson was named Senior Director, Corporate Strategy and Planning. In October 2011, Ms. Ellingson was promoted to Vice President, Corporate Communications and Investor Relations for St. Jude Medical, and in August 2012, she was promoted to Vice President, Corporate Relations. In July 2014, Ms. Ellingson's role was expanded and she was named Vice President, Global Communications where she now oversees internal and external marketing communications, investor relations, U.S. government affairs and corporate giving programs.

Jeff Fecho

Mr. Jeff A. Fecho is Vice President - Global Quality of St. Jude Medical Inc. Mr. Fecho joined St. Jude Medical in 2005 as Director of Quality for the Cardiovascular Division, served as Vice President of Quality for the Cardiovascular Division from 2008 to 2012 and became Vice President, Global Quality in January 2012. Prior to joining St. Jude Medical, he worked in research and development and quality operations for Boston Scientific, Inc.

John Brown

Mr. John W. Brown is Independent Presiding Director of St. Jude Medical Inc., since 2006. Chairman of the Board of Stryker Corporation, an orthopedic device company, from 1997 through December 2009. Chief Executive Officer of Stryker Corporation from 1977 through 2004. Chairman Emeritus of Stryker Corporation.

Richard Devenuti

Mr. Richard R. Devenuti is Independent Director of St. Jude Medical Inc. Mr. Devenuti is currently the President, Information Intelligence Group, a Division of EMC Corporation, a developer and provider of information infrastructure technology and solutions, from October 2010 to March 2015. Senior Vice President and Chief Operating Officer of the Information Intelligence Group from July 2008 to October 2010. Senior Vice President of Worldwide Services and IT of Microsoft Corporation, a software company, from December 2003 until January 2007. From March 1999 to December 2003, Vice President and Chief Information Officer of Microsoft Corporation. Director of Convergys Corporation since August 2009.

Stuart Essig

Mr. Stuart M. Essig is Independent Director of St. Jude Medical Inc., since 1999. Mr. Essig is currently the Chairman of the Board of Directors of Integra LifeSciences Holdings Corporation, a manufacturer of medical devices and implants, since January 2012. Director on the Integra Board of Directors since December 1997. Chief Executive Officer of Integra from December 1997 to January 2012, and President from December 1997 to November 2010. Currently a managing partner of Prettybook Partners (a provider of advisory services to healthcare businesses) since January 2012, a venture partner at Wellington Partners Advisory AG (a venture capital firm) since March 2013, and a senior advisor to TowerBrook Capital Partners (an investment management firm) since January 2012. Director of Owens & Minor, Inc. since October 2013.

Barbara Hill

Ms. Barbara B. Hill is Independent Director of St. Jude Medical Inc., since December 2007. Operating Partner of Moelis Capital Partners, a private equity firm, since March 2011. President, Chief Executive Officer and Director of ValueOptions, Inc., a managed behavioral health company, and FHC Health Systems, Inc., its parent company, from March 2006 to September 2010. Chairman and Chief Executive Officer of Woodhaven Health Services, an institutional pharmacy company, from August 2004 to March 2006. President and Director of Express Scripts, Inc., a pharmacy benefits management company, from April 2002 to October 2003. Director of Omega Healthcare Investors, Inc. since April 2013 and Integra LifeSciences Holdings Corporation since May 2013

Michael Rocca

Mr. Michael A. Rocca is Independent Director of St. Jude Medical Inc., since March 2004. Mr. Rocca Retired in 2000 from Mallinckrodt, Inc., a pharmaceutical and medical device manufacturer, where he was Senior Vice President and Chief Financial Officer from 1994 to 2000. Director of Hyatt Hotels Corporation since March 2008. Director of Lawson Software, Inc. from February 2003 to July 2011.

Stefan Widensohler

Mr. Stefan K. Widensohler has been appointed as Independent Director of St. Jude Medical, Inc., effective July 19, 2013. Previously served as a Director of St. Jude Medical from 2001 to 2010. Since 1992, President and Chief Executive Officer of KRAUTH Medical Group, which before 2012 was a European distributor of medical and surgical devices and services, and which now invests in healthcare start-up companies. Executive Vice President, Global Sales and Marketing of Invatec SpA, an Italian medical device company specializing in cardiology and peripheral vascular products, from 1996 to 2010 and Vice President, Global Sales after its acquisition by Medtronic, Inc. from 2010 to 2012. Director of LDR Holdings Corporation, a global medical device company, since May 2006.

Wendy Yarno

Ms. Wendy L. Yarno is Independent Director of St. Jude Medical Inc. Ms. Yarno was a Independent consultant in the life sciences industry. Chief Marketing Officer of HemoShear LLC, a biotechnology research company, from September 2010 through February 2012. From 2006 to 2008, Chief Marketing Officer for Merck & Co., Inc., a pharmaceutical company. From 2005 to 2006, General Manager, Business Unit, Merck & Co., Inc. From 2002 to 2005, Executive VP, Worldwide Human Health, Merck & Co., Inc. Director of Medivation, Inc., since April 2013, Aratana Therapeutics, Inc., since October 2013 and Durata Therapeutics, Inc., from August 2014 to October 2014.

J. Weigelt

Options Compensation

Search Stocks